Gilead to Raise Stake in Galapagos

Gilead has made a significant financial move to increase its stake, allowing it to deepen research into inflammatory diseases. This is the largest deal since CEO Dan O'Day took over, aiming to enhance the company's drug pipeline. Analysts view the deal as smart and financially savvy, providing Gilead access to Galapagos's drug pipeline without outright acquisition.

Who is the CEO of Gilead and when did they take over?

What are analysts' opinions on the financial aspects of the deal?